Country websites

Attention

For UK healthcare professionals (Nephrologists/Renal Nurses and Pharmacists) information only on Fresenius Medical Care’s medicines, medical devices, services, educational resources and more.

I'm a UK healthcare professional

Important notice – this site is intended for UK healthcare professionals only. By entering this site, and clicking on the button “Accepted and Confirmed”, you are confirming that you are a UK healthcare professional. In addition to educational resources, this site contains promotional information.

UK/HEMA/FME/0922/0005 Date of Preparation: November 2022

communication Data Link (cDL)

Interfacing the TDMS with external Hospital Information Systems (HIS)

    • Consistent use of patient data
    • Supports billing processes
    • Enables treatment documentation in electronic health records

    At a glance

    • Designed with you in mind, for seamless Therapy Data Management System (TDMS) interconnection with an existing Hospital Information System (HIS).
    • Efficient management of patient and treatment data starts with the correct information being available in the right place at the right time.
    • The primary function of cDL is to facilitate and process bidirectional communications between the Therapy Manager and the HIS, ensuring quality and efficiency.
    • Developed exclusively for application in a medical environment; no additional set-up programming is required.

    Advantages for administrators

    • Fresenius Medical Care middleware provides a number of advantages for clerical staff
    • Resource optimisation
    • Data protection
    • Transparency
    • Flexibility
    • Product simplicity

    Advantages for clinical staff

    Improving the experience of patients and clinical staff alike

    • Optimised treatment
    • Optimised patient care

    In Depth

    Resource optimisationReduces administration by eliminating the need for data to be stored in multiple databases.
    Data protectionData is only stored in the secure TDMS database and HIS.
    TransparencyRelevant data is available to all users at their respective interfaces.
    FlexibilityUses standard HIS protocols, but can be configured to comply with local systems.
    Product simplicityMinimal maintenance and no custom installation required.
    Optimised treatmentImproved availability of comprehensive patient data and lab results.
    Optimised patient careReduced administration allows more time for patient care.

    Additional information relating to multiBic or Calrecia can be found in the critical care section of our product information page.


    Adverse Events Reporting 

    Adverse events should be reported. Reporting forms and information can be found at 

    https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple app store. Adverse events should also be reported to Fresenius Medical Care on 01623 445100.

    UK/HEMA/FME/0922/0005 Date of Preparation: November 2022

    Related content